Camber Pharmaceuticals Inc
Jayni Panchal is a skilled professional with experience in financial analysis, tax preparation, and supply chain management. With a background in finance and financial management, Jayni has worked in various roles in different organizations, gaining expertise in areas such as tax accounting, corporate finance, and cash management. Jayni's education includes a Masters in Financial Analysis and Business Administration, along with a Bachelor's degree in Commerce. Currently employed as a Supply Chain Analyst at Camber Pharmaceuticals Inc, Jayni brings a diverse skill set to the table.
This person is not in any offices
Camber Pharmaceuticals Inc
Camber is made up of three groups with one common goal: to be the best generics company in the industry. Camber Pharmaceuticals is rapidly growing and had an industry-leading 28 product approvals in 2022. With the support of our parent company, Hetero, we are poised to have a record number of product approvals and launches in 2023. Hetero, a world leader in API production and vertical manufacturing, is the foundation upon which Camber has maintained a 99% service level for our customers for the past two years. Hetero is investing over $250 million in the next three years in Camber products. The research and development team consists of over 1,000 scientists working to expand the types of drugs Camber offers, including novel delivery systems and complex molecules.